The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kolbanov K.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Trakhtenberg A.Kh.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Pikin O.V.

FGBU "MNIOI im. P.A. Gertsena" Minzdrava Rossii

Glushko V.A.

P.A. Gertsen Moscow Research Cancer Institute, Russian Ministry of Health

Current possibilities of surgical treatment in patients with Stages I-III non-small-cell lung carcinoma

Authors:

Kolbanov K.I., Trakhtenberg A.Kh., Frank G.A., Pikin O.V., Glushko V.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2012;1(2): 4‑10

Views: 479

Downloaded: 7

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kolbanov KI, Trakhtenberg AKh, Frank GA, Pikin OV, Glushko VA. Current possibilities of surgical treatment in patients with Stages I-III non-small-cell lung carcinoma. P.A. Herzen Journal of Oncology. 2012;1(2):4‑10. (In Russ.)

МСФ на ЯМ
Close metadata
Recommended articles:
Patient-centered approach to asse­ssing tole­rability of anti­tumor treatment for oral cavity and oropharyngeal cancer. P.A. Herzen Journal of Onco­logy. 2024;(2):21-26
Mini­mally inva­sive surgical treatment of extramedullary tumors at the level of craniovertebral junction: expe­rience of the Burdenko Neurosurgical Center. Burdenko's Journal of Neurosurgery. 2024;(2):39-46
Infi­ltrating Endo­metriosis of the Distal Part of Round Uterine Liga­ment and It’s Asso­ciation with Nuck’s Dive­rticulum (Literature Review and Case Report). Russian Journal of Human Reproduction. 2024;(2):112-121
Surgical technique for aspi­ration of soft lens nucleus with preoperative femtosecond laser-assisted fragmentation. Russian Annals of Ophthalmology. 2024;(2-2):109-115
Surgical treatment of a patient with syphilitic aortitis. Piro­gov Russian Journal of Surgery. 2024;(5):123-128
Surgical treatment of idiopathic pulmonary artery aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):321-328
Thoracoscopic rese­ction of recu­rrent atypically loca­ted para­thyroid adenoma of ante­rior mediastinum in a patient with hype­rparathyroidism unde­rgoing renal replacement therapy. Piro­gov Russian Journal of Surgery. 2024;(6):81-87
Surgical treatment of chondromyxoid fibroma of ribs via thoracoabdominal access. Piro­gov Russian Journal of Surgery. 2024;(6):94-99
Predicting the risk of decreased ovarian rese­rve after surgical treatment of patients with deep infi­ltrative endo­metriosis using arti­ficial inte­lligence. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):92-102
Modern treatment of perianal fistulas following Crohn’s disease. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(2):49-56

The paper describes the state-of-the-art of surgical treatment in patients with non-small-cell lung carcinoma (NSLC). The immediate and late results of surgical and combination treatmentы are analyzed in 1420 patients, by taking into account the size of a primary tumor, the state of regional intrathoracic lymph node metastatic areas, and the histological subtype of NSLC. The frequency and pattern of postoperative complications and mortality rates are shown. Indications for the volume of surgical care and adjuvant tumor treatment are characterized. Prognostic factors influencing survival are identified.

Keywords:

non-small-cell lung carcinoma
surgical treatment
prognostic factors

Authors:

Kolbanov K.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Trakhtenberg A.Kh.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Pikin O.V.

FGBU "MNIOI im. P.A. Gertsena" Minzdrava Rossii

Glushko V.A.

P.A. Gertsen Moscow Research Cancer Institute, Russian Ministry of Health

List of references:

  1. Chissov V.I., red. Algoritmy diagnostiki i lecheniya zlo­kachestvennykh novoobrazovanii. M.: FGU "MNIOI im. P.A. Gertsena" Minzdravsotsrazvitiya Rossii; 2010.
  2. Volkov S.M. Otsenka effektivnosti i puti sovershenstvovaniya khirurgii nemelkokletochnogo raka legkogo: Avtoref. dis. ... d-ra med. nauk. M.; 2005.
  3. Starikov V.I., Trunov G.V. Rak legkogo. Khar'kov: "OOO Katran KPK"; 2002.
  4. Trakhtenberg A.Kh., Chissov V.I. Rak legkogo. M.: GEOTAR-Media; 2009.
  5. Kharchenko V.P., Khmelevskii E.V. Kombinirovannoe i khirurgicheskoe lechenie raka legkogo. V kn.: Materialy VI Vserossiiskogo s''ezda onkologov. Rostov-na-Donu, 2005; 1: 345.
  6. Chissov V.I., Starinskii V.V., Petrova G.V., red. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2010 godu. M.: FGU "MNIOI im. P.A. Gertsena"; 2011.
  7. Chissov V.I., Starinskii V.V., Petrova G.V., red. Zlokachestvennye novoobrazovaniya v Rossii v 2010 godu (zabolevaemost' i smertnost'). M.: FGU "MNIOI im. P.A. Gertsena"; 2012.
  8. Betticher D.C., Hsu Schmitz S.F., Tötsch M., Hansen E., Joss C., von Briel C. et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br. J. Cancer. 2006; 94 (8): 1099-106.
  9. Caldarella A., Crocetti E., Comin C.E., Janni A., Pegna A.L., Paci E. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications. Cancer. 2006; 107 (4): 793-8.
  10. Carretta A., Ciriaco P., Melloni G., Sayed I. Results of surgical treatment after neoadjuvant chemotherapy for stage III non-small cell lung cancer. World J. Surg. 2008; 32 (12): 2636-42.
  11. Cerfolio R.J., Bryant A.S. Survival of patients with true pathologic stage I non-small cell lung cancer. Ann. Thorac. Surg. 2009; 88 (3): 917-22.
  12. Cerfolio R.J., Bryant A.S. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann. Thorac. Surg. 2008; 86 (2): 362-6; discussion 366-7.
  13. Crino L., Weder W., van Meerbeeck J., Felip E. Klinicheskie rekomendatsii ESMO po diagnostike, lecheniyu i nablyudeniyu pri nachal'nykh i mestno-rasprostranennykh stadiyakh nemelkokletochnogo raka legkogo (NMRL). Minimal'nye klinicheskie rekomendatsii evropeiskogo obshchestva meditsinskoi onkologii (ESMO): Per. s angl. M.: RONTs im. N.N. Blokhina; 2010: 155-69.
  14. Garcia-Yuste M., Matilla J.M., Duque J.L., Heras F., Cerezal L.J., Ramos G. Surgical treatment of lung cancer: comparative assessment of the staging systems of 1986 and 1997. Results in 500 consecutive patients. Arch. Bronconeumol. 2001; 37 (1): 54.
  15. Gonfiotti A., Crocetti E., Lopes Pegna A., Paci E., Janni A. Prognostic variability in completely resected pN1 non-small-cell lung cancer. Asian Cardiovasc. Thorac. Ann. 2008; 16 (5): 375-80.
  16. Hayashi Y., Tomiyama I., Ishii H., Ishiwa N., Itoh H., Nakayama H. et al. Prognostic assessment of the new UICC TNM classification for resected lung cancer. Kyobu Geka. 2000; 53 (11): 919-25.
  17. Arriagada R., Dunant A., Pignon J.P., Bergman B., Chabowski M., Grunenwald D. et al. Long-term results of the Internacional Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin-based chemotherapy in resected non-small cell cancer. J. Clin. Oncol. 2010; 28 (1): 35-42.
  18. Ma Q., Liu D., Guo Y., Shi B., Song Z., Tian Y. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2). Zhongguo Fei Ai Za Zhi. 2010; 13 (4): 342-8.
  19. Matsuguma H., Nakahara R., Ishikawa Y., Suzuki H., Inoue K., Katano S., Yokoi K. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved. Interact. Cardiovasc. Thorac. Surg. 2008; 7 (4): 573-7.
  20. Meacci E., Cesario A., Cusumano G., Lococo F., D'Angelillo R., Dall'armi V. et al. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt. Eur. J. Cardiothorac. Surg. 2011; 40 (3): 656-63.
  21. Ohta Y., Shimixu Y., Minato H., Matsumoto I., Oda M., Watanabe G. et al. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Ann. Thorac. Surg. 2006; 81 (2): 427-33.
  22. Pearson F.G., DeLarue N.C., Ilves R., Todd T.R., Cooper J.D. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J. Thorac. Cardiovasc. Surg. 1982; 83 (1): 1-11.
  23. Saito Y., Yamakawa Y., Kuriyama M., Fukai I., Kondo S., Yano T. et al. Evaluation of new TNM lung cancer classification. J. Thorac. Cardiovasc. Surg. 2000; 48: 499-505.
  24. Scotti V., Meattini I., Saieva C., Agresti B., de Luca Cardillo C., Bastiani P. et al. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. Radiother. Oncol. 2010; 96 (1): 84-8.
  25. Shimada Y., Tsuboi M., Saji H., Miyajima K., Usuda J., Uchida O. et al. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system. Ann. Thorac. Surg. 2009; 88 (5): 1583-8.
  26. Smolle-Juettner F.M., Maier A., Lindenmann J., Matzi V., Neubock N. Resection in stage I/II non-small cell lung cancer. Front. Radiat. Ther. Oncol. 2010; 42: 71-7.
  27. Tanaka F., Yanagihara K., Otake Y., Kawano Y., Miyahara R., Takenaka K., Katakura H. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer. Ann. Surg. Oncol. 2004; 11 (6): 612-8.
  28. Van Rens M.T., de la Riviere A.B., Elbers H.R., van Den Bosch J.M. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000; 117: 374-9.
  29. Zhang X., Zhang B., Gao Y. Clinical application of adjuvant treatment after operation in patients with stage IIIa non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2010; 13 (4): 357-62.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.